1J5 Income Statement - TTM - Hyphens Pharma International Limited

Income Statement (TTM)

Hyphens Pharma International Limited Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.

All numbers are times 1,000,000 except per share units.

	2020 09-30	2020 12-31	2021 03-31	2021 06-30	2021 09-30	2021 12-31	2022 03-31	2022 06-30	2022 09-30	2022 12-31	2023 03-31	2023 06-30	2023 09-30	2023 12-31	2024 03-31	2024 06-30	2024 09-30	2024 12-31	2025 03-31	2025 06-30
Revenue	126	121	126	123	126	126	132	143	156	162	156	156	156	171	185	196	197	195	192	185
Change (%)		-3.84	4.19	-2.30	2.23	-0.01	4.86	8.17	9.54	3.78	-3.66	-0.04	0.04	9.09	8.65	5.49	0.55	-0.60	-1.65	-3.58
% of Revenue	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00

Cost Of Sales	83	79	83	78	80	78	82	89	96	100	96	97	99	110	120	128	127	127	125	119
Change (%)		-4.56	4.69	-6.37	3.11	-2.21	4.10	9.25	7.68	4.10	-4.02	1.01	2.30	10.44	9.54	6.66	-0.82	0.17	-1.67	-5.10
% of Revenue	66.12	65.63	65.94	63.20	63.74	62.34	61.89	62.51	61.45	61.63	61.40	62.04	63.44	64.23	64.75	65.47	64.58	65.08	65.06	64.04

Gross Operating Profit	43	42	43	45	46	47	50	54	60	62	60	59	57	61	65	68	70	68	67	67
Change (%)		-2.44	3.23	5.57	0.72	3.86	6.12	6.41	12.64	3.28	-3.07	-1.70	-3.65	6.74	7.05	3.34	3.15	-2.00	-1.60	-0.76
% of Revenue	33.88	34.37	34.06	36.80	36.26	37.66	38.11	37.49	38.55	38.37	38.60	37.96	36.56	35.77	35.25	34.53	35.42	34.92	34.94	35.96

SG&A	36	37	37	39	37	40	40	43	40	48	48	48	48	50	50	52	50	55	69	57
Change (%)		1.67	0.00	6.59	-6.18	8.07	0.00	9.00	-8.26	20.72	0.00	1.24	-1.23	4.57	-0.13	4.85	-4.63	9.92	25.24	-17.69
% of Revenue	28.66	30.30	29.09	31.73	29.12	31.47	30.01	30.25	25.33	29.47	30.58	30.98	30.58	29.32	26.95	26.79	25.41	28.10	35.78	30.54

R&D
Change (%)
% of Revenue

OpEx	119	116	120	117	120	118	123	132	142	148	145	145	148	160	172	180	182	182	180	175
Change (%)		-2.68	3.21	-2.40	2.91	-1.84	3.86	7.98	7.37	4.00	-2.28	0.62	1.88	7.73	8.01	4.66	1.05	-0.11	-1.18	-2.59
% of Revenue	94.78	95.93	95.03	94.93	95.56	93.81	92.91	92.75	90.91	91.10	92.40	93.02	94.72	93.54	92.99	92.26	92.72	93.17	93.62	94.58

Operating Income	7	5	6	6	6	8	9	10	14	14	12	11	8	11	13	15	14	13	12	10
Change (%)		-25.00	27.32	-0.38	-10.43	39.30	20.07	10.63	37.34	1.65	-17.77	-8.09	-24.41	33.44	18.00	16.50	-5.46	-6.83	-8.01	-18.11
% of Revenue	5.22	4.07	4.97	5.07	4.44	6.19	7.09	7.25	9.09	8.90	7.60	6.98	5.28	6.46	7.01	7.74	7.28	6.83	6.38	5.42

Interest Expense	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0	-1	-1	-1
Change (%)		0.92	-0.00	-2.73	2.80	-13.64	-0.00	18.95	-15.93	150.53	-0.00	37.39	-27.22	16.81	-0.00	15.83	-13.66	103.24	26.46	-6.93
% of Revenue	-0.09	-0.09	-0.09	-0.09	-0.09	-0.08	-0.07	-0.08	-0.06	-0.15	-0.15	-0.21	-0.15	-0.16	-0.15	-0.16	-0.14	-0.29	-0.37	-0.36

Net Income	7	6	6	6	6	7	8	9	12	11	10	9	7	9	10	10	10	10	8	6
Change (%)		-9.29	0.19	0.34	3.92	6.32	15.51	9.93	34.90	-3.21	-16.03	-8.13	-23.18	27.37	15.71	5.06	-0.03	-2.10	-18.48	-22.26
% of Revenue	5.40	5.09	4.90	5.03	5.11	5.44	5.99	6.09	7.50	6.99	6.10	5.60	4.30	5.02	5.35	5.33	5.30	5.22	4.32	3.49

Source: Capital IQ

Hyphens Pharma International Limited - Income Statement (TTM)

Income Statement (TTM)